T helper cell activation and human retroviral pathogenesis

Microbiological Reviews

Volumn 60, Issue 4, 1996, Pages 722-742

  Copeland, Karen F T ^a   Heeney, Jonathan L ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; ARTICLE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOPATHOGENESIS; LYMPHOCYTE ACTIVATION; NONHUMAN; RETROVIRUS INFECTION; T CELL LEUKEMIA; VIRUS EXPRESSION;

HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; UNIDENTIFIED RETROVIRUS;

EID: 0029837110     PISSN: 01460749     EISSN: None     Source Type: Journal    
DOI: 10.1128/mmbr.60.4.722-742.1996     Document Type: Article

References (371)

1. Abehsira-Amar, O., M. Gibert, M. Joliy, J. Theze, and D. L. Jankovic. 1992. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J. Immunol. 148:3820-3829.
2. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T-lymphocytes. J. Exp. Med. 178:2231-2235.
3. Alkhatib, G., C. Combadiere, C. C. Broder, Y. Feng, P. E. Kennedy, P. M. Murphy, and E. A. Berger. 1996. CC CKR5: A RANTES, MIP-1α, and MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272:1955-1958.
4. Amiesen, J. C., and A. Capron. 1991. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12:102-105.
5. Anderson, R. E., S. C. Shiboski, R. Royce, N. P. Jewell, W. Lang, and A. Winkelstein, Jr. 1991. CD8+ lymphocytes and progression to AIDS in HIV-infected men: some observations. AIDS 5:213-215.
6. Antoni, B. A., P. Sabbatini, A. B. Rabson, and E. White. 1995. Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. J. Virol. 69:2384-2392.
7. Asjo, B., D. Cefai, P. Debre, Y. Dudoit, and B. Autran. 1993. A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes. J. Virol. 67:4395-4398.
8. Auwerx, J., and P. Sassone-Corsi. 1991. IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation. Cell 64:983-993.
9. Azuma, M., D. Ito, H. Yagita, K. Okumura, J. H. Phillips, L. Lanier, and C. Samoza. 1993. B70 is a second ligand for CTLA-4 and CD28. Nature (London) 366:76-79.
10. Badley, A. D., J. A. McElhinny, P. J. Leibson, D. H. Lynch, M. R. Alderson, and C. V. Paya. 1996. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J. Virol. 70:199-206.
11. ras contributes to HIV-1 activation in T-cells. FEBS Lett. 304:261-264.
12. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrie, N. Haigwood, R.-P. Sekaly, and T. H. Finkel. 1992. Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis. J. Exp. Med. 176:1099-1106.
13. + T cell suppressor activities. J. Immunol. 156:4476-4483.
14. Barre-Sinousi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamarel, T. Gruest, C. Dauguet, C. Axler-Blin, F. Vezin-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphocyte retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-870.
15. 2 accumulation by a mechanism which differs from DNA damage checkpoint control. J. Virol. 70:2324-2331.
16. Beraud, C., S.-C. Sun, P. Ganchi, D. W. Ballard, and W. C. Greene. 1994. Human T-cell leukemia virus type 1 Tax associates with and is negatively regulated by the NF-κB p100 gene product: implications for viral latency. Mol. Cell. Biol. 14:1374-1382.
17. Berkhout, B., A. Gatignol, A. B. Rabson, and K.-T. Jeang. 1990. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell 62:757-767.
18. Berkhout, B., and K.-T. Jeang. 1992. Functional roles for the TATA promoter and enhancers in basal and Tat induced expression of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 66:139-149.
19. Berkhout, B., R. H. Silverman, and K.-T. Jeang. 1989. Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell 59:273-282.
20. Betz, M., and B. S. Fox. 1990. Regulation and development of cytochrome c-specific IL-4 producing T cells. J. Immunol. 145:1046-1052.
21. Bhagavati, S., G. Ehrlich, R. W. Kula, S. Kwok, J. Sninsky, V. Udani, and B. J. Poiesz. 1988. Detection of human T-cell lymphoma/leukemia virus type I DNA and antigen in spinal fluid and blood of patients with chronic progressive myelopathy. N. Engl. J. Med. 318:1141-1147.
22. Blazquez, M. V., J. A. Madueno, R. Gonzalez, R. Jurado, W. W. Bachovchin, J. Pena, and E. Munoz. 1992. Selective decrease of CD26 expression in T cells from HIV-1-infected individuals. J. Immunol. 149:3073-3077.
23. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J. Virol. 68:6103-6110.
24. + T lymphocytes during HIV infection. J. Immunol. 156: 2282-2293.
25. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, J. Daley, G. Gray, and L. M. Nadler. 1993. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc. Natl. Acad. Sci. USA 90:11059-11063.
26. Breen, E. C., A. R. Rezai, K. Nakajima, G. N. Beall, R. T. Mitsuyasu, T. Hirano, T. Kishimoto, and O. Martinez-Maza. 1990. Infection with HIV is associated with elevated IL-6 levels and production. J. Immunol, 144:480-484.
27. Brinchmann, J. E., J. H. Dobloug, B. H. Heger, L. L. Haaheim, M. Sannes, and T. Egeland. 1994. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency virus type 1 infection: functional and clinical correlations. J. Infect. Dis. 169:730-738.
28. + T cells. J. Immunol. 144:2961-2966.
29. Brunet, J. F., F. Denizot, M. F. Luciani, M. Roux-Dosseto, M. Suzan, M. G. Mattei, and P. Golstein. 1987. A new member of the immunoglobulin superfamily - CTLA-4. Nature (London) 328:267-270.
30. Callebaut, C., B. Krust, E. Jacotot, and A. G. Hovanessian. 1993. T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells. Science 262:2045-2050.
31. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
32. Carbonari, M., M. Cibati, M. Cherchi, D. Sbarigia, A. M. Pesce, L. Dell'anna, A. Modica, and M. Fiorilli. 1994. Detection and characterization of apoptotic peripheral blood lymphocytes in HIV infection and cancer chemotherapy by a novel flow immunocytometric method. Blood 83:1245-1255.
33. + cells. AIDS Res. Hum. Retroviruses 11:789-794.
34. Carmichael, A., X. Jin, P. Sissons, and L. Borysiewicz. 1993. Quantitative analysis of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 177:249-256.
35. Caron, C., R. Rousset, C. Beraud, V. Moncollin, J.-M. Egly, and P. Jalinot. 1993. Functional and biochemical interaction of the HTLV-1 Taxi transactivator with TBP. EMBO J. 12:4269-4278.
36. Caruso, A., A. Cantalamessa, S. Licenziati, L. Peroni, E. Prati, F. Martinelli, A. D. Canaris, S. Folghera, R. Gorla, A. Balsari, R. Cattaneo, and A. Turano. 1994. Expression of CD28 on CD8(+) and CD4(+) lymphocytes during HIV infection. Scand. J. Immunol. 40:485-490.
37. Catovsky, D., M. F. Greaves, M. Rose, D. A. G. Galton, A. W. G. Goolden, D. R. McCluskey, J. M. White, I. Lampert, G. Bourikas, R. Ireland, A. I. Brownwell, J. M. Bridges, W. A. Blattner, and R. C. Gallo. 1982. Adult T-cell lymphoma-leukemia in blacks from the West Indies. Lancet i:639-643.
38. lck together with impairment of T cell activation. J. Immunol. 149:285-294.
39. Chang, T. L., C. M. Shea, S. Urioste, R. C. Thompson, W. H. Boom, and A. K. Abbas. 1990. Heterogeneity of helper/inducer T lymphocytes. III. Responses of IL-2 and IL-4 producing (Th1 and Th2) clones to antigens presented by different accessory cells. J. Immunol. 145:2803-2808.
40. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
41. Chen, B. K., R. T. Gandhi, and D. Baltimore. 1996. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nef. J. Virol. 70:6044-6053.
42. Chen, C.-H., K. J. Weinhold, J. A. Bartlett, D. P. Bolognesi, and M. Greenberg. 1993. CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism. AIDS Res. Hum. Retroviruses 9:1079-1086.
43. Chen, D., and E. V. Rothenberg. 1994. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179:931-942.
44. Chen, Y., V. K. Kuchroo, J. Inobe, D. A. Hafler, and H. L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237-1240.
45. Chen, Y.-M. A., A. Okayama, T.-H. Lee, N. Tachibana, N. Mueller, and M. Essex. 1991. Sexual transmission of human T-cell leukemia virus type I associated with the presence of anti-Tax antibody. Proc. Natl. Acad. Sci. USA 88:1182-1186.
46. Chirmule, N., T. W. McCloskey, R. Hu, V. S. Kalyanaraman, and S. Pahwa. 1995. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J. Immunol. 155: 917-924.
47. Chlichlia, K., G. Moldenhauer, P. T. Daniel, M. Busslinger, L. Gazzolo, V. Schirrmacher, and K. Khazaie. 1993. Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene 10:269-277.
48. Choe, H., M. Farzan, Y. Sun, N. Sullivan, B. Rollins, P. D. Ponath, L. Wu, C. R. Mackay, G. LaRosa, W. Newman, N. Gerard, C. Gerard, and J. Sodroski. 1996. The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85:1135-1148.
49. + T lymphocytes during HIV-1 infection. J. Acquired Immune Defic. Syndr. 7:245-253.
50. Chung, I. Y., and E. N. Benveniste. 1990. Tumor necrosis factor-α production by astrocytes. Induction by lipopolysaccharide. IFN-γ. and IL-1β. J. Immunol. 144:2999-3007.
51. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721-1724.
52. Clerici, M., A. Sarin, R. L. Coffman, T. A. Wynn, S. P. Blatt, C. W. Hendrix, S. F. Wolf, G. M. Shearer, and P. A. Henkart. 1994. Type1/type2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. USA 91:11811-11815.
53. Clerici, M., and G. M. Shearer. 1993. A TH1-TH2 switch is a critical step in the etiology of HIV infection. Immunol. Today 15:312-315.
54. Clerici, M., and G. M. Shearer. 1996. Correlates of protection in HIV infection and the progression of HIV infection to AIDS. Immunol. Lett. 51:69-73.
55. Clevers, H., B. Alarcon, T. Wileman, and C. Terhorst. 1988. The T-cell receptor/CD3 complex: a dynamic protein ensemble. Annu. Rev. Immunol. 6:629-662.
56. + T cells. Science 270:1811-1815.
57. Cocks, B. G., C.-C. J. Chang, J. M. Carbllido, H. Yssel, J. E. de Vries, and G. Aversa. 1995. A novel receptor involved in T-cell activation. Nature (London) 376:260-263.
58. Copeland, K. F. T., A. G. M. Haaksma, D. Derse, J. Goudsmit, and J. L. Heeney. 1993. Cytochemical analysis of human T-cell leukaemia virus I LTR-regulated beta-galactosidase gene expression using a novel integrated cell system. J. Virol. Methods 45:161-167.
59. Copeland, K. F. T., A. G. M. Haaksma, J. Goudsmit, and J. L. Heeney. 1994. Calcium-mediated inhibition of phorbol ester and tax trans-activation of the human T-cell leukaemia virus-1. J. Gen. Virol. 75:1623-1631.
60. Copeland, K. F. T., A. G. M. Haaksma, J. Goudsmit, P. H. Krammer, and J. L. Heeney. 1994. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I tax. AIDS Res. Hum. Retroviruses 10:1259-1268.
61. Copeland, K. F. T., P. J. Hendrikx, A. G. M. Haaksma, S. Fiering, R. van Lier, J. Goudsmit, and J. L. Heeney. 1995. Comparison of the response to T-cell activation by integrated HIV-1 and HTLV-1 LTR-lacZ vectors. Virology 209:633-636.
62. + T-cells is not lentivirus specific. AIDS Res. Hum. Retroviruses 11: 321-1326.
63. + T-cells is dependent on the NFAT-1 element. AIDS Res. Hum. Retroviruses 12:143-148.
64. Copeland, K. F. T., et al. Unpublished observations.
65. Cuthbert, R. J. G., C. A. Ludlam, J. Tucker, C. M. Steel, D. Beatson, S. Rebus, and J. F. Peutherer. 1990. Five year prospective study of HIV infection in the Edinburgh hemophiliac cohort. Br. Med. J. 301:956-960.
66. D'Andrea, A., M. Rengaraju, N. M. Valiante, J. Chehimi, M. Kubin, M. Aste, S. H. Chan, M. Kobayashi, D. Young, E. Nickbarg, R. Chizzonite, S. F. Wolf, and G. Trinchieri. 1992. Production of natural killer cell stimulatory factor interleukin 12 by peripheral blood mononuclear cells. J. Exp. Med. 176:1387-1398.
67. Debatin, M. K., A. Fahrig-Farssner, S. Enenkel-Stoodt, W. Kreuz, A. Bender, and P. H. Krammer. 1994. High expression of apo-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children. Blood 83:3101-3103.
68. Debatin, K.-M., C. K. Goldman, R. Bamford, T. A. Waldman, and P. H. Krammer. 1990. Monoclonal antibody-mediated apoptosis in adult T-cell leukaemia. Lancet 335:497-500.
69. + T cells producing Th2-type cytokines. FASEB J. 9:81-86.
70. Del Prete, G. F., M. De Carli, C. Mastromauro, D. Macchia, R. Biagiotti, M. Ricci, and S. Romagnani. 1991. Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88:346-350.
71. Deng, H. K., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmom, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature (London) 381:661-666.
72. Depper, J. M., W. J. Leonard, M. Kronke, T. A. Waldmann, and W. C. Greene. 1984. Augmented T cell growth factor receptor expression in HTLV-1-infected human leukemic T cells. J. Immunol. 133:1691-1695.
73. De Revel, T., A. Mabondzo, G. Gras, B. Delord, P. Roques, F. Boussin, Y. Neveux, M. Bahuau, H. J. A. Fleury, and D. Dormont. 1993. In vitro infection of human macrophages with human T-cell leukemia virus type I. Blood 81:1598-1606.
74. Ding, L., P. Linsley, L.-Y. Huang, R. Germain, and E. Shevach. 1993. IL-10 inhibits macrophage co-stimulatory activity by selectively inhibiting the upregulation of B7 expression. J. Immunol. 151:1224-1239.
75. Donaldson, Y. K., J. E. Bell, J. W. Ironside, R. P. Brettle, J. R. Robertson, A. Busuttil, and P. Simmonds. 1994. Redistribution of HIV outside the lymphoid system with onset of AIDS. Lancet 343:382-385.
76. Dorantz, B. J., J. Rucker, Y. Yi, R. J. Smyth, M. Samson, S. C. Peiper, M. Parmentier, R. G. Collman, and R. W. Doms. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149-1158.
77. + cells is mediated by the chemokine receptor CC-CKR-5. Nature (London) 381:667-673.
78. Droge, W., K. M. Murthy, C. Stahl-Hennig, S. Hartung, R. Plesker, S. Rouse, E. Peterhans, R. Kinscherf, T. Fischbach, and H.-P. Eck. 1993. Plasma amino acid dysregulation after lentiviral infection. AIDS Res. Hum. Retroviruses 9:807-809.
79. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1989. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5794-5798.
80. Eck, H.-P., H. Mertens, H. Rasokat, G. Fatgenheuer, C. Pohl, M. Schrappe, V. Daniel, H. Naher, D. Petzoldt, P. Drings, and W. Droge. 1992. T4+ cell numbers are correlated with plasma glutamate and cystine levels: association of hyperglutamataemia with immunodeficiency in diseases with different etiologies. Int. Immunol. 4:7-13.
81. Edelman, S., and S. Zola-Pazner. 1990. Response of mononuclear cells from HIV-infected patients to B-cell mitogens: correlation with immunological and clinical features of disease progression. AIDS 4:859-864.
82. Ehret, A., M. O. Westendorp, Ingrid Herr, K.-M. Debatin, J. L. Heeney, R. Frank, and P. H. Krammer. 1996. Resistance of chimpanzee T cells to human immunodeficiency virus type 1 Tat-enhanced oxidative stress and apoptosis. J. Virol. 70:6502-6507.
83. Elovaara, I., S. Koenig, A. Yambusu Brewah, R. M. Woods, T. Lehky, and S. Jacobson. 1993. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J. Exp. Med. 177:1567-1573.
84. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature (London) 345:84-86.
85. + T cell from human immunodeficiency virus-infected persons. J. Exp. Med. 182:1759-1767.
86. Fahey, J. L., J. M. G. Taylor, R. Deteld, B. Hofmann, R. Melmed, P. Nishanian, and J. V. Giorgi. 1990. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1. N. Eng. J. Med. 322:166-172.
87. + T cells by stimulation through the CD28 pathway. Clin. Exp. Immunol. 105:225-230.
88. Fan, J., H. Z. Bass, and J. L. Fahey. 1993. Elevated IFNτ and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 151: 5031-5040.
89. Feng, Y., C. C. Broder, P. E. Kennedy, and E. A. Berger. 1996. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane domain, G-protein coupled receptor. Science 272:872-877.
90. Feuer, G., S. A. Stewart, S. M. Baird, F. Lee, R. Feuer, and I. S. Y. Chen. 1995. Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. J. Virol. 69:1328-1333.
91. Finkel, T. H., G. Tudor-Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:129-134.
92. Fiorentino, D. F., M. W. Bond, and T. R. Mosmann. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
93. Fiorentino, D. F., A. Zlotnik, P. Vieira, T. R. Mosmann, M. Howard, K. W. Moore, and A. Ogarra. 1991. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146:3444-3451.
94. + T cell subset with an unrestricted cytokine profile. J. Immunol. 143:518-525.
95. Foster, S., P. Beverley, and R. Aspinall. 1995. gp120-induced programmed cell death in recently activated T cells without subsequent ligation of the T cell receptor. Eur. J. Immunol. 25:1778-1782.
96. Franchini, G., F. Wong-Staal, and R. C. Gallo. 1984. Human T-cell leukemia virus (HTLV-1) transcripts in fresh and cultured cells of patients with adult T-cell leukemia. Proc. Natl. Acad. Sci. USA 81:6207-6211.
97. Fuchs, D., A. Haussen, G. Reibregger, E. R. Werner, G. Werner-Felmayer, M. P. Dierich, and H. Wachter. 1989. Interferon gamma concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J. Acquired Immune Defic. Syndr. 2:158-162.
98. Fuchs, D., G. M. Shearer, R. N. Boswell, D. R. Lucey, M. Clerici, G. Reibnegger, E. Werner, R. A. Zajaz, and H. Wachter. 1991. Negative correlation between blood cell counts and serum neopterin concentration in patients with HIV-1 infection. AIDS 5:209-213.
99. SRF causes the aberrant induction of cellular immediate early genes through CarG boxes. Genes Dev. 6:2066-2076.
100. Fujita, M., and H. Shiku. 1995. Differences in sensitivity to induction of apoptosis among rat fibroblast cells transformed by HTLV-I tax gene or cellular nuclear oncogenes. Oncogene 11:15-20.
101. Fukuhara, S., Y. Hinuma, Y. I. Gotoh, and H. Uchino. 1983. Chromosome aberrations in T lymphocytes carrying adult T-cell leukemia-associated antigens (ATLA) from healthy adults. Blood 61:205-207.
102. Garcia, J. A., D. Harrich, E. Soutanakis, F. Wu, R. Mitsuyasu, and R. B. Gaynor. 1989. Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation. EMBO J. 8:765-778.
103. Gardner, P. 1989. Calcium and T lymphocyte activation. Cell 59:15-20.
104. Gazzolo, L., and M. Due Dodon. 1987. Direct activation of resting T cells by HTLV-1. Nature (London) 326:714-717.
105. Gehri, R., S. Hahn, M. Rothen, M. Steuerwald, R. Nuesch, and P. Erb. 1996. The Fas receptor in HIV infection: expression on peripheral blood lymphocytes and role in the depletion of T cells. AIDS 10:9-16.
106. + exchange and phospholipid turnover. Immunol. Rev. 95:59-87.
107. Gessain, A., F. Barin, and J. C. Vernant. 1985. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet ii:407-410.
108. Gessain, A., A. Louie, O. Gout, R. C. Gallo, and G. Franchini. 1991. Human T-cell leukemia-lymphoma virus type 1 (HTLV-1) expression in fresh peripheral blood mononuclear cells from patients with tropical spastic paraparcsis/HTLV-1-associated myclopathy. J. Virol. 65:1628-1633.
109. Gessain, A., F. Saal, M.-L. Giron, J. Lasneret, S. Lagaye, O. Gout, G. de The, F. Sigaux, and J. Peries. 1990. Cell surface phenotype and human T lymphotropic virus type 1 antigen expression in 12 T cell lines derived from peripheral blood and cerebrospinal fluid of West Indian, Guyanese and African patients with tropical spastic paraparesis. J. Gen. Virol. 71:333-341.
110. Gibellini, D., A. Caputo, C. Celeghini, A. Bassini, M. La Placa, S. Capitani, and G. Zauli. 1995. Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus type-1 (HIV-1) infection. Br. J. Haematol. 89:24-33.
111. Gimmi, C. D., G. J. Freeman, J. G. Gribben, G. Gray, and L. M. Nadler. 1993. Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc. Natl. Acad. Sci. USA 90:6586-6590.
112. Gitlin, S. D., J. Dittmer, R. C. Shin, and J. N. Brady. 1993. Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Taxi and Etsl. J. Virol. 67:7307-7316.
113. Giulian, D., E. Wendt, K. Vaca, and C. A. Noonan. 1993. The envelope glycoprotein of human immunodeficiency virus type 1 stimulates release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA 90:2769-2773.
114. Godfried, M. H., T. van der Poll, J. Jansen, J. A. Romijn, J. K. M. Eeftinck-Schattenkerk, E. Endert, S. J. H. van Deventer, and H. P. Sauerwein. 1993. Soluble receptors for tumor necrosis factor: a putative marker of disease progression in HIV infection. AIDS 7:33-43.
115. Gootenberg, J. E., F. W. Ruscetti, J. M. Mier, A. Gazdar, and R. C. Gallo. 1981. Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor. J. Exp. Med. 154:1403-1418.
116. Gougeon, M.-L., S. Garcia, J. Heeney, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauguet, and L. Montagnier. 1093. Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res. Hum. Retroviruses 9:553-563.
117. Gougeon, M.-L., H. Lecoeur, A. Dulioust, M.-G. Enouf, M. Crouvoisier, C. Goujard, T. Debord, and L. Montagnier. 1996. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156:3509-3521.
118. Gowda, S. D., B. S. Stein, N. Mohagheghpour, C. J. Benike, and E. G. Engleman. 1989. Evidence that T cell activation is required for HIV-1 entry in CD4+ lymphocytes. J. Immunol. 142:773-780.
119. H2 predominance in HIV-infected individuals. Science 265:248-252.
120. Green, J., C. Begley, D. Wagner, T. Waldmann, and G. Jay. 1989. trans-activation of granulocyte-macrophage colony-stimulating factor and the interleukin-2 receptor in transgenic mice carrying the human T-lymphotropic virus type 1 tax gene. Mol. Cell. Biol. 9:4731-4737.
121. Gribben, J. G., G. J. Freeman, V. A. Boussiotis, P. Rennert, C. L. Jellis, E. Greenfield, M. Barber, V. A. Restivo, Jr., X. Ke, G. S. Gray, and L. M. Nadler. 1995. CTLA4 mediates antigen-specific apoptosis of human cells. Proc. Natl. Acad. Sci. USA 92:811-815.
122. Griffin, D. E., J. C. McArthur, and D. R. Comblath. 1991. Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 41:69-74.
123. Groux, H., G. Torpier, D. Monte, Y. Mouton, A. Capron, and J. C. Amieson. 1992. Activation-induced death by apoptosis from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-338.
124. Gruters, R. A., S. A. Otto, B. J. M. AI, A. J. Verhoeven, C. L. Verweij, R. A. W. Van Lier, and F. Miedema. 1991. Non-mitogenic T-cell activation signals are sufficient for induction of human immunodeficiency virus transcription. Eur. J. Immunol 21:167-172.
125. Gruters, R. A., F. G. Terpstra, R. De Jong, C. J. M. Van Noesel, R. A. W. Van Lier, and F. Miedema. 1990. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Eur. J. Immunol. 20:1039-1044.
126. Gupta, P., L. Kinsley, J. Armstrong, M. Ding, M. Cottrill, and C. Rinaldo. 1993. Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 196:586-595.
127. Gupta, S. 1986. Study of activated T cells in man. II. Interleukin 2 receptor and transferrin receptor expression on T cells and production of interleukin 2 in patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex. Clin. Immunol. Immunopathol. 38:93-100.
128. Gutheil, W. G., M. Subramanyam, G. R. Flentke, D. G. Sanford, E. Munoz, B. T. Huber, and W. W. Bachovchin. 1994. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): A possible mechanism for Tat's immunosuppressive activity. Proc. Natl. Acad. Sci. USA 91:6594-6598.
129. Guyot, D. J., O. J. Trask, J. M. Andrews, G. C. Newbound, and M. D. Lairmore. 1996. Stimulation of the CD2 receptor pathway induces apoptosis in human T lymphotropic virus type I-infected cell lines. J. Acquired Immune Defic. Syndr. 11:317-325.
130. Haanen, J. B. A. G., R. de Waal Maleflt, P. C. M. Res, R. R. P. de Vries, and H. Spits. 1991. Selection of a human T helper type 1-like T cell subset by mycobacteria. J. Exp. Med. 174:583-592.
131. Harada, S., Y. Koyanagi, H. Nakashima, N. Kobayashi, and N. Yamamoto. 1986. Tumor promoter, TPA, enhances replication of HTLV-III/LAV. Virology 154:249-258.
132. Haraguchi, S., R. A. Good, and N. K. Day. 1995. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today 16:595-603.
133. Harding, F. A., J. G. McArthur, J. A. Gross, D. H. Raulet, and J. P. Allison. 1992. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature (London) 356:607-609.
134. Harper, K., C. Balzano, E. Rouvier, M. G. Mattei, M. F. Luciani, and P. Goldstein. 1991. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J. Immunol. 147:1037-1044.
135. Harrich, D., J. Garcia, F. Wu, R. Mitsuyasu, J. Gonzalez, and R. Gaynor. 1989. Role of Sp1 binding domains in in vivo transcriptional regulation of the human immunodeficiency virus 1 long terminal repeat. J. Virol. 63: 2585-2591.
136. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Modes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905-907.
137. Hattori, T., T. Uchiyama, T. Toibana, K. Takatsuki, and H. Uchino. 1981. Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies. Blood 58:645-647.
138. Heeney, J., R. Jonker, W. Koornstra, R. Dubbes, H. Niphuis, A.-M. Di Rienzo, M.-L. Gougeon, and L. Montagnier. 1993. The resistance of HIV-infected chimpanzees to progression to AIDS correlates with absence of HIV-related T-cell dysfunction. J. Med. Primatol. 22:194-200.
139. Heeney, J. L. 1995. AIDS: a disease of impaired Th-cell renewal? Immunol. Today 16:515-519.
140. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115.
141. Hinuma, Y., H. Komoda, and T. Chosa. 1982. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study. Int. J. Cancer 29:631-635.
142. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. Kinoshita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78:6476-6480.
143. Hirai, H., J. Fujisawa, T. Suzuki, K. Ueda, M. Muramatsu, A. Tsuboi, N. Arai, and M. Yoshida. 1992. Transcriptional activator Tax of HTLV-1 binds to the NFkappa B presursor p105. Oncogene 7:1737-1742.
144. Hirai, H., T. Suzuki, J.-I. Fujisawa, J.-I. Inoue, and M. Yoshida. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA 91:3584-3588.
145. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
146. Hollsberg, P., L. J. Ausubel, and D. A. Hafler. 1994. Human T cell lymphotropic virus type I-induced T cell activation. Resistance to
147. Hollsberg, P., K. W. Wucherpfennig, L. J. Ausubel, V. Calvo, B. E. Bierer, and D. A. Hafler. 1992. Characterization of HTLV-1 in vivo infected T cell clones. J. Immunol. 148:3256-3263.
148. Holmgren, A. 1985. Thioredoxin. Annu. Rev. Biochem. 54:237-271.
149. Honda, M., K. Kitamura, K. Matsuda, Y. Yokota, N. Yamamoto, R. Mitsuyasu, J.-C. Cherman, and T. Tokunaga. 1989. Soluble IL-2 receptor in AIDS: correlation of its serum level with the classification of HIV-induced diseases and its characterization. J. Immunol. 142:4248-4255.
150. Hoshino, H., M. Shimoyama, M. Miwa, and T. Sugimura. 1983. Detection of lymphocytes producing a human retrovirus associated with adult T-cell leukemia by syncytia induction assay. Proc. Natl. Acad. Sci. USA 80:7337-7341.
151. Hoyos, B., D. W. Ballard, E. Bohnlein, M. Siekevitz, and W. C. Greene. 1989. Kappa B specific DNA binding proteins: role in the activation of the interleukin-2 gene. Science 244:457-460.
152. β sequences. Science 254:860-862.
153. + multifunctional T cell clones following infection with human T lymphotropic virus type I. J. Immunol. 143: 1327-1333.
154. Israel, N., U. Hazan, J. Alcami, A. Munier, F. Arenzana-Seisdedos, F. Bachelerie, A. Israel, and J.-L. Virelizier. 1989. Tumor necrosis factor stimulates transcription of HIV-1 in human T lymphocytes, independently and synergistically with mitogens. J. Immunol. 143:3956-3960.
155. Iwakura, Y., M. Tosu, E. Yoshida, M. Takiguchi, K. Sato, I. Kitajima, K. Nishioka, K. Yamamoto, T. Takeda, M. Hatanaka, H. Yamamoto, and T. Sekiguchi. 1991. Induction of inflammatory arthropathy resembling arthritis in mice transgenic for HTLV-I. Science 253:1026-1028.
156. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-1 associated neurological disease. Nature (London) 348:245-248.
157. + cells of the CD4 and CD8 lineages. AIDS 7:613-624.
158. Jassoy, C., R. P. Johnson, B. A. Navia, J. Worth, and B. D. Walker. 1992. Detection of a vigorous HIV-1-specific cytotoxic T lymphocyte response in cerebrospinal fluid from infected persons with AIDS dementia complex. J. Immunol. 149:3113-3119.
159. Jeang, K. T., S. Wilden, O. Semmes, and S. Wilson. 1990. HTLV-1 trans-activator protein, tax, is a trans-repressor of the human β-polymerase gene. Science 247:1082-1084.
160. Jenkins, M. K., P. S. Taylor, S. D. Norton, and K. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T lymphocytes. J. Immunol, 147:2461-2466.
161. Jones, K. A., J. T. Kadonaga, P. A. Luciw, and R. Tjian. 1986. Activation of the AIDS retrovirus by the cellular transcription factor Sp1. Science 232: 755-759.
162. Jones, K. A., P. A. Luciw, and N. Duchange. 1988. Structural arrangements within the 5′-untranslated leader regions of the HIV-1 and HIV-2 promoters. Genes Dev. 2:1101-1114.
163. Kadison, P., H. T. Poteat, K. M. Klein, and D. V. Faller. 1990. Role of protein kinase A in tax transactivation of the human T-cell leukemia virus type 1 long terminal repeat. J. Virol. 64:2141-2148.
164. Kalinkovich, A., H. Engelmann, N. Harpaz, R. Burnstein, D. Wallach, and Z. Bentwich. 1992. Elevated serum levels of soluble tumor necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin. Exp. Immunol. 89:351-355.
165. + lymphocytes. Clin. Exp. Immunol. 93:350-355.
166. Kamine, J., T. Subramanian, and G. Chinnadurai. 1991. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA 88:8510-8514.
167. Kamine, J., T. Subramanian, and G. Chinnadurai. 1993. Activation of a heterologous promoter by human immunodeficiency virus type 1 Tat requires Sp1 and is distinct from the mode of activation by acidic transcriptional activators. J. Virol. 67:6828-6834.
168. Kannagi, M., H. Shida, H. Igarashi, K. Kuruma, H. Murai, Y. Aono, I. Maruyama, M. Osame, T. Hattori, H. Inoko, and S. Harada. 1992. Target epitope in the tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66:2928-2933.
169. Katsikis, P. D., E. S. Wunderlich, C. A. Smith, L. A. Herzenberg, and L. A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181:2029-2036.
170. Kaufman, J. D., G. Valandra, G. Rodriquez, G. Bushar, C. Giri, and M. A. Norcross. 1987. Phorbol ester enhances human immunodeficiency virus-promoted gene expression and acts on a repeated 10-base-pair functional enhancer element. Mol. Cell. Biol. 7:3759-3766.
171. Kestens, L., G. Vanham, P. Gigase, G. Young, I. Hannet, F. Vanlangendonck, F. Hulstaert, and B. A. Bach. 1992. Expression of activation antigens, HLA-DR and CD38 on CD8 lymphocytes during HIV-1 infection. AIDS 6:793-797.
172. + T lymphocytes during HIV-1 infection. Clin. Exp. Immunol. 95:436-441.
173. Kimata, J. J., T. J. Palker, and L. Ratner. 1993. The mitogenic activity of human T-cell leukemia virus type 1 is T-cell associated and requires the CD2/LFA-3 activation pathway. J. Virol. 67:3134-3141.
174. Kimata, J. J., and L. Ratner. 1991. Temporal regulation of viral and cellular gene expression during human T-lymphotropic virus type I-mediated lymphocyte immortalization. J. Virol. 65:4398-4407.
175. 1 gene of human T-cell leukemia virus type 1 in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86: 5620-5624.
176. Kinter, A. L., G. Poli, W. Maury, T. M. Folks, and A. S. Fauci. 1990. Direct and cytokine-mediated activation of protein kinase C induces human immunodeficiency virus expression in chronically infected promonocytic cells. J. Virol. 64:4306-4312.
177. Kira. J.-I., Y. Itoyama, Y. Koyanagi, J. Tateishi, M. Kishikawa, S.-I. Akizuki, I. Kobayashi, N. Toki, K. Sueishi, and H. Sato. 1992. Presence of HTLV-1 proviral DNA in central nervous system of patients with HTLV-1-associated myelopathy. Ann. Neurol. 31:39.
178. Klas, C., K.-M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625-630.
179. + cells from nonhuman primates. J. Acquired Immune Defic. Syndr. 7:438-446.
180. Koenig, S., P. Earl, D. Powell. G. Pantaleo, S. Merli, B. Moss, and A. S. Fauci. 1988. Group-specific, major histocompatibility complex class-1 restricted cytotoxic responses to human immunodeficiency virus-1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-infected individual. Proc. Natl. Acad. Sci. USA 85:8638-8642.
181. Koenig, S., H. E. Gendelman, J. M. Orenstein, M. C. Dal Canto, G. H. Pezeshkpour, M. Yungbluth, F. Janotta, A. Aksamit, M. A. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
182. Koenig, S., R. M. Woods, Y. A. Brewah, A. J. Newell, G. M. Jones, E. Boone, J. W. Adelsberger, M. W. Baseler, S. M. Robinson, and S. Jacobson. 1993 Characterisation of MHC class 1 restricted cytotoxic T-cell responses to Tax HTLV-1 infected patients with neurologic disease. J. Immunol. 156: 3874-3883.
183. + T cells. J. Exp. Med. 173:759-762.
184. Koup, R. A., J. T. Safrti, Y. Cao, C. A. Andrews, G. McLeod, W. Borkowsky, C. Farthing, and D. D. Ho. 1994. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 68:4650-4655.
185. Koyanagi, Y., W. A. O'Brien, J. Q. Zhao, D. W. Golde, J. C. Gasson, and I. S. Y. Chen. 1988. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241:1673-1675.
186. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:459-465.
187. Lacoste, J., L. Petropoulos, N. Pepin, and J. Hiscott. 1995. Constitutive phosphorylation and turnover of IκBα in human T-cell leukemia virus type I-infected and Tax-expressing cells. J. Virol. 69:564-569.
188. 2-microglobulin and human immunodeficiency virus infection. AIDS 1:123-127.
189. Lal, R. B., and D. L. Rudolph. 1991. Constitutive production of interleukin-6 and tumor necrosis factor-α from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II. Blood 78:571-574.
190. Landay, A. L., C. E. Mackewicz, and J. A. Levy. 1993. An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status. Clin. Immunol. Immunopathol. 69:106-116.
191. Lane, H. C., J. M. Depper, W. C. Greene, G. Whalen, T. A. Waldman, and A. S. Fauci. 1985. Quantitative analysis of immune function in patients with AIDS: evidence for a selective defect in soluble antigen recognition. N. Engl. J. Med. 313:79-84.
192. Lane, H. C., H. Masur, L. C. Edgar, G. Whalen, A. H. Rook, and A. S. Fauci. 1983. Abnormalities of B cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453-458.
193. Lang, W., M. Perkins, R. E. Anderson, R. Royce, N. Jewell, and W. Winkelstein, Jr. 1993. Patterns of T-lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J. Acquired Immune Defic. Syndr. 2:63-69.
194. Lanoix, J., J. Lacoste, N. Pepin, N. Rice, and J. Hiscott. 1994. Overproduction of NFκB2 (lyt-10) and c-Rel: a mechanism for HTLV-1 Tax-mediated trans-activation via the NF-κB signalling pathway. Oncogene 9:841-852.
195. Lasky, L. A., G. Nakamura, D. H. Smith, C. Fennie, C. Shimasaki, E. Patzner, P. Berman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor. Cell 50:975-985.
196. Lathey, J. L., S. Kanangat, and B. T. Rouse. 1994. Differential expression of tumor necrosis factor α and interleukin 1β compared with interleukin 6 in monocytes from human immunodeficiency virus-positive individuals measured by polymerase chain reaction. J. Acquired Immune Defic. Syndr. 7:109-115.
197. Laurent-Crawford, A. G., B. Krust, Y. Riviére, C. Desgranges, S. Muller, M. Kieny, C. Dauguet, and A. G. Hovanessian. 1993. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells. AIDS Res. Hum. Retroviruses 9:761-773.
198. Lederer, J. A., J. S. Liou, S. Kim, N. Rice, and A. H. Lichtman. 1996. Regulation of NFκB activation in T helper 1 and T helper 2 cells. J. Immunol. 156:56-63.
199. Lederer, J. A., J. S. Liou, M. D. Todd, L. H. Glimcher, and A. H. Lichtman. 1994. Regulation of cytokine gene expression in T helper cell subsets. J. Immunol. 152:77-86.
200. Lederer, J. A., V. L. Perez, L. DesRoches, S. M. Kim, A. K. Abbas, and A. H. Lichtman. 1996. Cytokine transcriptional events during helper T cell subset differentiation. J. Exp. Med. 184:397-406.
201. Lehky, T. J., E. P. Cowan, L. A. Lampson, and S. Jacobson. 1994. Induction of HLA class I and class II expression in human T-lymphotropic virus type I-infected neuroblastoma cells. J. Virol. 68:1854-1863.
202. Leno, M., R. M. Simpson, F. S. Bowers, and T. J. Kindt. 1995. Human T lymphocyte virus 1 from a leukemogenic cell line mediates in vivo and in vitro lymphocyte apoptosis. J. Exp. Med. 181:1575-1580.
203. Lenschow, D. J., G. Huei-Ting Su, L. A. Zuckerman, N. Nabavi, C. L. Jellis, G. S. Gray, J. Miller, and J. A. Bluestone. 1993. Expression and functional significance of an additional ligand for CTLA-4. Proc. Natl. Acad. Sci. USA 90:11054-11058.
204. Levine, B., Q. Huang, J. Y. Isaacs, J. C. Reed, D. E. Griffith, and J. M. Hardwick. 1993. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature (London) 361:739-742.
205. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289.
206. Li, C. J., D. J. Friedman, C. Wang, V. Metelev, and A. B. Pardee. 1995. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein. Science 268:429-431.
207. Liegler, T. J., and D. P. Stites. 1994. HIV-1 gp120 and anti-gp120 induce reversible unresponsiveness in peripheral CD4 T lymphocytes. J. Acquired Immune Defic. Syndr. 7:340-348.
208. Linsley, P. S., W. Brady, L. S. Grosmaire, N. K. Damle, and J. A. Ledbetter. 1991. CTLA-4 is a second receptor for the B cell activation antigen B7. J. Exp. Med. 174:561-569.
209. Linsley, P. S., J. L. Greene, P. Tan, J. Bradshaw, J. A. Ledbetter, C. Anasetti, and N. K. Damle. 1992. Coexpression and functional cooperation of CTLA-4 and CD28 on activated lymphocytes. J. Exp. Med. 176:1595-1604.
210. Lipton, S. A. 1993. Human immunodeficiency virus-infected macrophages, gp120, and N-methyl-D-aspartate receptor-mediated neurotoxicity. Ann. Neurol. 33:227-228.
211. Liu, J., N. D. Perkins, R. M. Schmid, and G. J. Nabel. 1992. Specific NFκB subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66:3883-3887.
212. Ljunggren, K., P.-A. Broliden, L. Morfeldt-Manson, M. Jundal, and B. Wahren. 1988. IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages. Clin. Exp. Immunol. 73:343-347.
213. Lu, Y., N. Touzjian, M. Stenzel, T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1990, Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1. J. Virol. 64:5226-5229.
214. Lu, Y.-Y., Y. Koga, K. Tanaka, M. Sasaki, G. Kimura, and K. Nomoto. 1994. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1. J. Virol. 68:390-399.
215. Mabrouk, K., J. Van Rietschoten, E. Vives, H. Darbon, H. Rothat, and J.-M. Sabatier. 1991. Lethal neurotoxicity in mice of the basic domains of HIV and SIV Rev proteins. FEBS Lett. 289:13-17.
216. Macatonia, S. E., R. Lau, S. Patterson, A. J. Pinching, and S. C. Knight. 1990. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology 71:38-45.
217. + T cells suppress human immunodeficiency virus replication by inhibiting viral transcription. Proc. Natl. Acad. Sci. USA 92:2308-2312.
218. + cell anti-HIV activity: nonlytic suppression of virus replication. AIDS Res. Hum. Retroviruses 6:1039-1050.
219. H0 cells. Science 265:244-248.
220. Maguer-Satta, V., L. Gazzolo, and M.Duc Dodon. 1995. Human immature thymocytes as target cells of the leukemogenic activity of human T-cell leukemia virus type I. Blood 86:1444-1452.
221. Maldarelli, F., H. Sato, E. Berthold, J. Orenstein, and M. A. Martin. 1995. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1. J. Virol. 69:6457-6465.
222. Marfella, A., V. Ruocco, A. Capobianco, M. Perna, G. Santelli, G. Frigione, S. K. Kyalwazi, R. D. Mugerwa, D. Serwadda, E. Beth-Giraldo, and G. Giraldo. 1989. Neopterin and alpha-interferon in patients affected by Kaposi's sarcoma from Africa. Eur. J. Cancer Clin. Oncol. 25:1145-1150.
223. Markovitz, D. M., M. J. Smith, J. Hilfinger, M. C. Hannibal, B. Petryniak, and G. J. Nabel. 1992. Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and κB elements. J. Virol. 66:5479-5484.
224. I to a responsive element in the viral long terminal repeat. Mol. Cell. Biol. 9:4152-4160.
225. Maruyama, M., H. Shibuya, H. Harada, M. Hatekayama, M. Seiki, T. Fujita, J. Inoue, M. Yoshida, and T. Taniguchi. 1987. Evidence for aberrant activation of the interleukin-2 autocrine loop by HTLV-1 encoded p40x and T3/Ti complex triggering. Cell 48:343-350.
226. Matsuyama, T., N. Kobayashi, and N. Yamamoto. 1991. Cytokines and HIV infection: is AIDS a tumor necrosis factor disease? AIDS 5:1405-1417.
227. + T cell function in the course of human immunodeficiency virus infection: decline of both naive and memory alloreactive T cells. J. Clin. Invest. 94:1947-1952.
228. Meyaard, L., S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P. M. Keet, and F. Miedema. 1992. Programmed cell death of T-cells in HIV-1 infection. Science 257:217-219.
229. Meyaard, L., S. A. Otto, I. P. M. Keet, M. T. L. Roos, and F. Miedema. 1994. Programmed death of T cells in human immunodeficiency virus infection: no correlation with progression to disease. J. Clin. Invest. 93:982-988.
230. + T helper cell depletion occurs. J. Clin. Invest. 82:1908-1914.
231. Mier, J. W., and R. C. Gallo. 1980. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc. Natl. Acad. Sci. USA 77:6134-6138.
232. Miyamoto, K., N. Tomita, A. Ishii, H. Nonaka, T. Kondo, T. Tanaka, and K.-J. Kitajima. 1984. Chromosome abnormalities of leukemia cells in adult patients with T-cell leukemia. JNCI 73:353-362.
233. Miyawaki, T., T. Uehara, R. Nihu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149: 3753-3758.
234. Morgan, D. A., F. W. Ruscetti, and R. Gallo. 1976. Selective in vitro growth of T lymphocytes from normal human bone marrow. Science 193:1007-1008.
235. Morimoto, C., C. I. Lord, C. Zhang, J. S. Duke-Cohan, N. L. Letvin, and S. F. Schlossman. 1994. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl. Acad. Sci. USA 91:9960-9964.
236. Morrow, C. D., J. Park, and J. K. Wakefield. 1994. Viral gene products and replication of the human immunodeficiency type 1 virus. Am. J. Physiol. 266:C1135-C1156.
237. Mosmann, T. R., H. Cherwinski, M. W. Bond, M. A. Giedlin, and R. L. Coffman. 1986. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136:2348-2357.
238. Mukhopadhyaya, R., and M. Reza Sadaie. 1993. Nucleotide sequence analysis of HTLV-I isolated from cerebrospinal fluid of a patient with TSP/ HAM: comparison to other HTLV-I isolates. AIDS Res. Hum. Retroviruses 9:109-114.
239. Munoz, E., A. M. Zubiaga, M. Merrow, N. P. Sauter, and B. T. Huber. 1990. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95-103.
240. Muro-Cacho, C. A., G. Pantaleo, and A. Fauci. 1995. Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with the stage of disease or viral burden. J. Immunol. 154:5555-5566.
241. Murphy, E. L., B. Hanchard, J. P. Figueroa, W. N. Gibbs, W. S. Loiters, M. Campbell, J. J. Goedert, and W. A. Blattner. 1989. Modeling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lymphotropic virus type I. Int. J. Cancer 43:250-253.
242. Nabel, G., and D. Baltimore. 1987. An inducible factor activates expression of human immunodeficiency virus in T cells. Nature (London) 326:711-713.
243. Nakamura, M., Y. Itoyama, M. Kuroki, S. Nakano, S. Kondoh, S. Nagafuchi, J. Kira, I. Ichinose, K. Mitsugi, K. Anzai, H. Mori, M. Fukui, S. Okamura, and Y. Niho. 1992. Increase in peripheral B lymphocytes committed to the production of monoreactive and high affinity antibodies to HTLV-1 in patients with HAM/TSP. J. Neuroimmunol. 37:35-45.
244. Nakamura, M., M. Niki, K. Ohtani, and K. Sugamura. 1989. Differential activation of the 21-base-pair enhancer element of human T-cell leukemia virus type I by its own trans-activator and cyclic AMP. Nucleic Acids Res. 17:5207-5221.
245. Natazuka, T., T. Umemiya-Okada, T. Matsui, T. Saida, and Y. Nakao. 1993. FK506 and cyclosporin A regulate proliferation and proto-oncogene expression in HTLV-1-associated myelopathy/tropical-spastic-paraparesis-derived T cells. Int. J. Cancer 54:348-354.
246. Navikas, V., J. Link, B. Wahren, CH. Persson, and H. Link. 1994. Increased levels of interferon-gamma (IFN-γ), IL-4 and transforming growth factor-beta (TGF-β) mRNA expressing blood mononuclear cells in human HIV infection. Clin. Exp. Immunol. 96:59-63.
247. Nerenberg, M., S. Hinrichs, K. Reynolds, G. Khoury, and G. Jay. 1987. The tat gene of HTLV-1 induces mesenchymal tumors in transgenic mice. Science 237:1324-1329.
248. Neumann, M., T. Grieshammer, S. Chuvpilo, B. Kneitz, M. Lohoff, A. Schimpl, B. R. Franza, and E. Serfling. 1995. RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J. 14:1991-2004.
249. Newell, M. K., L. J. Haughn, C. R. Maroun, and M. H. Julius. 1990. Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen. Nature (London) 347:286-289.
250. Niewiesk, S., S. Daenke, C. E. Parker, G. Taylor, J. Weber, S. Nightingale, and C. R. M. Bangham. 1995. Naturally occurring variants of human T-cell leukemia virus type I Tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of Tax. J. Virol. 69:2649-2653.
251. Nomoto, M. Y. Utatsu, Y. Soejima, and M. Osame. 1991. Neopterin in cerebrospinal fluid: a useful marker lor diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Neurology 41:457.
252. Noronha, I. L., V. Daniel, K. Schimpf, and G. Opelz. 1992. Soluble IL-2 receptor and tumour necrosis factor-α in plasma of haemophilia patients infected with HIV. Clin. Exp. Immunol. 87:287-292.
253. Osame, M., K. Usuku, S. Izumo, N. Ijichi, H. Amitini, A. Igata, M. Matsuto, and M. Tara. 1986. HTLV-1 associated myelopathy, a new clinical entity. Lancet i:1031-1032.
254. Osmond, D. H., S. Shiboski, P. Bacchetti, E. E. Winger, and A. R. Moss. 1991. Immune activation markers and AIDS prognosis. AIDS 5:505-511.
255. Oyaizu, N., N. Chirmule, V. S. Kalyanaraman, W. W. Hall, R. A. Good, and S. Pahwa. 1990. Human immunodeficiency virus type 1 envelope glycoprotein gp120 produces immune defects in CD4+ T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 87:2379-2383.
256. Oyaizu, N., T. W. McCloskey, M. Coronesi, N. Chirmule, V. S. Kalyanaraman, and S. Pawha. 1993. Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. Blood 82:3392-3400.
257. Oyaizu, N., and S. Pahwa. 1995. Role of apoptosis in HIV disease pathogenesis. J. Clin. Immunol. 15:217-231.
258. Pantaleo, G., and A. S. Fauci. 1995. New concepts in the immunopathogenesis of HIV infection. Annu. Rev. Immunol. 13:487-512.
259. Pantaleo, G., S. Menzo, M. Vaccarezza, C. Graziosi, O. J. Cohen, J. F. Demarest, D. Montegiori, J. M. Orenstein, C. Fox, L. K. Schrager, J. B. Margolick, S. Buchbinder, J. V. Giorgi, and A. S. Fauci. 1995. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N. Engl. J. Med. 332:209-216.
260. Parker, C. E., S. Daenke, S. Nightingale, and C. R. M. Bangham. 1992. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as patients with tropical spastic paraparesis. Virology 188:628-636.
261. Parker, C. E., S. Nightingale, G. P. Taylor, J. Weber, and C. R. M. Bangham. 1994. Circulating anti-Tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously. J. Virol. 68:2860-2868.
262. Parronchi, P., D. Macchia, M.-P. Piccinni, P. Biswas, C. Simonelli, E. Maggi, M. Ricci, A. A. Ansari, and S. Romagnani. 1991. Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc. Natl. Acad. Sci. USA 88:4538-43.
263. Perini, G., S. Wagner, and M. R. Green. 1995. Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax. Nature (London) 376:602-605.
264. Pinching, A. J. 1988. Factors affecting the natural history of human immunodeficiency virus infection. Immunol. Rev. 1:23-38.
265. Pinching, A. J., and K. E. Nye. 1990. Defective signal transduction - a common pathway for cellular dysfunction in HIV infection? Immunol. Today 11:256-259.
266. Pinto, L., M. J. Covas, and R. M. M. Victorino. 1991. Loss of CD45RA and gain of CD45RO after m vitro activation of lymphocytes from HIV-infected patients. Immunology 73:147-150.
267. Pizzolo, G., F. Vinante, L. Morosato, G. Nadali, M. Chilosi, G. Gandini, A. Sinicco, R. Raiteri, G. Semenzato, H. Stein, and G. Perona. 1994. High serum level of the soluble form of CD30 molecule in the early phase of HIV-1 infection as an independent predictor of progression to AIDS. AIDS 8:741-745.
268. Flanelles, V., J. B. M. Jowett, Q.-X. Li, Y. Xie, B. Hahn, and I. S. Y. Chen. 1996. Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol. 70:2516-2524.
269. Poiesz, BJ., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77:7415-7419.
270. Poli, G., P. Bressler, A. Kinter, E. Duh, W. L. Timmer, A. Rabson, J. S. Justement, S. Stanley, and A. S. Fauci. 1990. IL-6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with TNF by transcriptional and post-transcriptional mechanisms. J. Exp. Med. 172:151-158.
271. Poli, G., and A. S. Fauci. 1992. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res. Hum. Retroviruses 8:191-197.
272. Popovic, M., N. Flomenberg, D. J. Volkman, D. Mann, A. S. Fauci, B. Dupont, and R. C. Gallo. 1984. Alteration of T-cell functions by infection with HTLV-I or HTLV-II. Science 226:459-462.
273. Popovic, M., G. Lange-Wantzin, P. S. Sarin, D. Mann, and R. C. Gallo. 1983. Transformation of human umbilical cord blood T cells by human T cell leukemia/lymphoma virus. Proc. Natl. Acad. Sci. USA 80:5402-5406.
274. Poteat, H., P. Kadison, K. McGuire, L. Park, R. E. Park, J. G. Sodroski, and W. A. Haseltine. 1989. Response of the human T-cell leukemia virus type I long terminal repeat to cyclic AMP. J. Virol. 63:1604-1611.
275. Powrie, F., and R. L. Coffman. 1993. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 14:270-274.
276. Pozzati, R., J. Vogel, and G. Jay. 1990. The human T-lymphotropic virus type I tax gene can cooperate with the ras oncogene to induce neoplastic transformation of cells. Mol. Cell. Biol. 10:413-417.
277. lck SH3 domain binds to PI 3-kinase but not PI 4-kinase. Mol. Cell. Biol. 13:7708-7717.
278. Procaccia, S., A. Lazzarin, A. Colucci, A. Gasparini, P. Forcellini, D. Lanzanova, C. U. Foppa, R. Novati, and C. Zanussi. 1987. IgM, IgG and IgA rheumatoid factors and circulating immune complexes in patients with AIDS and AIDS-related complex with serological abnormalities. Clin. Exp Immunol. 67:236-244.
279. x) occurs through similar but functionally distinct target sequences. J. Virol. 63:2987-2994.
280. Ramsdell, F., M. S. Seaman, R. E. Miller, K. S. Picha, M. K. Kennedy, and D. H. Lynch. 1994. Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int. Immunol. 6:1545-1553.
281. Rao, L., M. Debbas, P. Sabbatini, D. Hockenbery, S. Korsmeyer, and E. White. 1992. The adenovirus E1A proteins induce apoptosis, which is inhibited by the R1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 89:7742-7746.
282. Re, M. C., G. Zauli, D. Gibellini, G. Furlini, E. Ramazzotti, P. Monari, S. Ranieri, S. Capitani, and M. La Placa. 1993. Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 7:1049-1055.
283. Rinaldo, C., X.-L. Huang, Z. Fan, M. Ding, L. Beltz, A. Logar, D. Panicali, G. Mazzara, J. Liebmann, M. Cottrill, and P. Gupta. 1995. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activation and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 69:5838-5842.
284. Riviere, Y. 1994. Virus-specific cytotoxic T lymphocyte responses in patients infected with human immunodeficiency virus. Cell. Mol. Biol. 40(Suppl. 1):45-48.
285. Romagnani, S. 1992. Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int. Arch. Allergy Immunol. 98:279-285.
286. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.
287. Romagnani, S., F. Annunziato, R. Manetti, F. Almerigogna, R. Biagiotti, M. G. Giudizi, A. Ravina, V. Gianno, L. Tomaevic, and E. Maggi. 1996. Role for CD30 in HIV expression. Immunol. Lett. 51:83-88.
288. H2 cytokines in HIV infection. Immunol. Rev. 140:73-92.
289. Rosenberg, Z., and A. Fauci. 1990. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol. Today 11:176-180.
290. Sandstrom, P. A., D. Pardi, C. S. Goldsmith, D. Chengying, A. M. Diamond, and T. M. Folks. 1996. bcl-2 expression facilitates human immunodeficiency virus type 1-mediated cytopathic effects during acute spreading infections. J. Virol. 70:4617-4622.
291. Santelli, G., G. Melillo, A. Marfella, M. Napolitano, V. D'Alessio, R. A. Satriano, E. Beth-Giraldo, G. Giraldo, M. Perna, and G. Castello. 1988. Urinary neopterin and immunological features in patients with Kaposi's sarcoma. Eur. J. Cancer Clin. Oncol. 24:1391-1396.
292. Schlesinger, M., O. Afik, O. Loves, S. Maayan, and R. Rabinowitz. 1990. Changes in the level of soluble CD2 molecules in the serum of HIV-infected individuals. Cancer Detect. Prev. 14:347-351.
293. + cells in HIV-1-infected and high-risk individuals. Clin. Immunol. Immunopathol. 73:252-260.
294. Schmidt, A., L. Hennighausen, and U. Siebenlist. 1990. Inducible nuclear factor binding to the κB elements of the human immunodeficiency virus enhancer in T cells can be blocked by cyclosporin A in a signal-dependent manner. J. Virol. 64:4037-4041.
295. Schols, D., and E. Declercq. 1996. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production. J. Virol. 70:4953-4960.
296. Schreck, R., R. Grassman, B. Fleckenstein, and P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NFκB by human T-cell leukemia virus type I tax protein. J. Virol. 66:6288-6293.
297. Scott-Algara, D., F. Vullier, M. Marasescu, J. de Saint-Martin, and G. Didhiero. 1991. Serum levels of IL-2, IL-1α, TNFα and soluble receptor of IL-2 in HIV-infected patients. AIDS Res. Hum. Retroviruses 7:381-386.
298. + T cells. Annu. Rev. Immunol. 12:635-673.
299. + T cells from T cell receptor transgenic mice. J. Exp. Med. 176:1091-1098.
300. Seligman, M., L. Chess, J. L. Fahey, A. S. Fauci, P. J. Lachman, J. L'Age-Ster, J. Ngu, A. J. Pinching, F. S. Rosen, T. J. Spira, and J. W. Wybran. 1984. AIDS - an immunologic reevaluation. N. Engl. J. Med. 311:1286-1292.
301. Seligman, M., A. J. Pinching, F. S. Rosen, J. L. Fahey, R. M. Khaitov, D. Klatzmann, S. Koenig, N. Luo, J. Ngu, G. Reithmuller, and T. J. Spira. 1987. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann. Intern. Med. 107: 234-242.
302. Sellins, K. S., and J. J. Cohen. 1987. Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J. Immunol. 139:3199-3206.
303. Selmaj, K. W., M. Farooq, W. T. Norton, C. S. Raine, and C. F. Brosnan. 1990. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 144:129-135.
304. Sethi, K. K., and H. Naher. 1986. Elevated titers of cell-free interleukin-2 receptor in serum and cerebrospinal fluid specimens of patients with acquired immunodeficiency syndrome. Immunol. Lett. 13:179-184.
305. Shaw, J.-P., P. J. Ut, D. B. Durand, J. J. Toole, E. A. Emanuel, and G. Crabtree. 1988. Identification of a putative regulator of early T-cell activation genes. Science 241:202-205.
306. Shearer, G. M., D. C. Bernstein, K. S. K. Tung, C. S. Via, R. Redfield, S. Z. Salahuddin, and R. C. Gallo. 1986. A model for the selective loss of MHC self-restricted T-cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J. Immunol. 137:2514-2521.
307. Sheppard, H. W., and M. S. Ascher. 1992. The relationship between AIDS and immunologic tolerance. J. Acquired Immune Defic. Syndr. 5:143-147.
308. Shor-Posner, G., A. Basit, Y. Lu, C. Cabrejos, J. Chang, M. Fletcher, E. Mantero-Atienza, and M. K. Baum. 1993. Hypercholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am. J. Med. 94:515-519.
309. Silvestris, F., P. Cafforio, M. A. Frassanito, M. Tucci, A. Romito, S. Nagata, and F. Dammacco. 1996. Overexpression of Fas antigen on T cells in advanced HIV-1 infection: differential ligation constantly induces apoptosis. AIDS 10:131-141.
310. Simmonds, P., D. Beatson, R. J. G. Cuthbert, H. Watson, B. Reynolds, J. F. Peutherer, J. V. Parry, C. A. Ludlam, and C. M. Steel. 1991. Determinants of HIV disease progression: six year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet 338:1159-1163.
311. Simpson, D. M., and M. Tagliati. 1994. Neurologic manifestations of HIV infection. Ann. Intern. Med. 121:769-785.
312. Smith, D. H., R. A. Byrn, S. A. Marsters, T. Gregory, J. E. Groopman, and D. J. Capon. 1987. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science 238:1704-1707.
313. Stevenson, M., T. L. Stanwick, M. P. Dempsey, and C. A. Lamonica. 1990. HIV-1 replication is controlled at the level of T cell activation and proviral integration. EMBO J. 9:1551-1560.
314. Street, N. E., J. H. Schmacher, T. A. T. Fong, H. Bass, D. F. Fiorentino, J. A. Leverah, and T. R. Mosmann. 1990. Heterogeneity of mouse helper T cells: evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells. J. Immunol. 144:1629-1639.
315. Subramanyam, M., W. G. Gutheil, W. W. Bachovchin, and B. T. Huber. 1993. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 150:2544-2553.
316. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873-879.
317. Sugamura, K., M. Fujii, M. Kannagi, M. Sakitani, M. Takeuchi, and Y. Hinuma. 1984. Cell surface phenotypes and expression of viral antigens of various human cell lines carrying human T-cell leukemia virus. Int. J. Cancer 34:221-228.
318. Sugamura, K., and Y. Hinuma. 1993. Human retroviruses: HTLV-I and HTLV-II, p. 399-435. In J. A. Levy (ed.), The retroviridae, vol. 2. Plenum Press, New York.
319. Suzuki, M., H. Uno, A. Kiyomizu, Y. Kubuki, K. Yamashita, K. Maeda, H. Matsuoka, K. Tsuda, and H. Tsubouchi. 1995. Observation of T-cell surface antigens in the clinical course of adult T-cell leukemia: case report of a spontaneous remission. Acta Haematol. 93:40-45.
320. Suzuki, M., H. Uno, K. Yamashita, T. Toyama, Y. Kubuki, K. Maeda, H. Matsuoka, S. Ohtaki, and H. Tsubouchi. 1996. Clinical significance of CD45RO expression on peripheral blood mononuclear cells in HTLV-1-infected individuals. Br. J. Haematol. 92:401-409.
321. Suzuki, T., J.-I. Fujisawa, M. Toita, and M. Yoshida. 1993. Transactivator Tax of human T-cell leukemia virus type I (HTLV-I) interacts with cAMP-responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-I. Proc. Natl. Acad. Sci. USA 90: 610-614.
322. Suzuki, T., H. Hirai, J.-I. Fujisawa, T. Fujita, and M. Yoshida. 1993. A trans-activator Tax of human T-cell leukemia virus type I binds to NF-κB p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-κB site and CarG box. Oncogene 8:2391-2397.
323. Swain, S. L., G. Huston, S. Tonkonogy, and A. Weinberg. 1991. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:2991-3000.
324. Tanaka, A., C. Takahashi, S. Yamaoka, T. Nosaka, M. Maki, and M. tanaka. 1990. Oncogenic transformation by the tax gene of human T-cell leukemia virus type 1 in vitro. Proc. Natl. Acad. Sci. USA 87:1071-1075.
325. Tanimura, A., H. Teshima, J.-I. Fujisawa, and M. Yushida. 1993. A new regulatory element that augments the tax-dependent enhancer of human T-cell leukemia virus type I and cloning of cDNAs encoding its binding proteins. J. Virol. 67:5375-5382.
326. Tendler, C. L., S. J. Greenberg, W. A. Blattner, A. Manns, E. Murphy, T. Fleisher, B. Hanchard, O. Morgan, J. D. Burton, D. L. Nelson, and T. A. Waldman. 1990. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus I-associated myelopathy: pathogenic implications and a rationale for immunotherapy. Proc. Natl. Acad. Sci. USA 87:5219-5222.
327. Tendler, C. L., S. J. Greenberg, J. D. Burton, D. Danielpour, S.-J. Kim, W. A. Blattner, A. Manns, and T. A. Waldman. 1991. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis. J. Cell. Biochem. 46:302-311.
328. Tong-Starksen, S. E., P. A. Luciw, and B. M. Peterlin. 1989. Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat. J. Immunol. 142:702-707.
329. Trentin, L., S. Garbisa, R. Zambello, C. Agostini, C. Caenazzo, C. Di Francesco, A. Cipriani, E. Francavilla, and G. Semenzato. 1992. Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type-1-infected patients. J. Infect. Dis. 166:731-737.
330. Tsuda, H., R.-W. Huang, and K. Takatsuki. 1993. Interleukin-2 prevents programmed cell death in adult T-cell leukemia cells. Jpn. J. Cancer Res. 84:431-437.
331. Tsuda, H., and K. Takatsuki. 1984. Specific decrease in T3 antigen density in adult T-cell leukemia cells I. Flow microfluorometric analysis. Br. J. Cancer 50:843-845.
332. Tsukada, N., M. Matsuda, K. Miyagi, and N. Yanagisawa. 1991. Soluble CD4 and CD8 in the peripheral blood of patients with multiple sclerosis and HTLV-1-associated myelopathy. J. Neuroimmunol. 35:285-293.
333. Tsuruta, L., H.-J. Lee, E. S. Masuda, N. Koyano-Nakagawa, N. Arai, K. Arai, and T. Yokota. 1995. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP. J. Immunol. 154:5255-5264,
334. + T cell populations. Eur. J. Immunol. 25:2907-2916.
335. + T cells from HIV-gp120-induced apoptosis. Eur. J. Immunol. 25: 2917-2922.
336. Umehara, F., S. Izumo, A. T. Ronquillo, K. Matsumuro, E. Sato, and M. Osame. 1994. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 53:72-77.
337. Umehara, F., A. Nakamura, S. Izumo, R. Kubota, S. Ijichi, N. Kashio, K.-I. Hashimoto, K. Usuku, E. Sato, and M. Osame. 1994. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-1-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J. Neuropathol. Exp. Neurol. 53:617-624.
338. Van de Perre, P., P. Lepage, A. Simonon, C. Desgranges, D. G. Hitimana, A. Bazubagira, C. van Goethem, A. Kleinschmidt, F. Bex, K. Broliden, V. Erfle, F. Gotch, and A. Burny. 1992. Biological markers associated with prolonged survival in African children maternally infected by the human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 8:435-442.
339. Vanham, G., L. Kestens, G. Penne, C. Goilav, P. Gigase, R. Colebunders, M. Vandenbruaene, J. Goeman, G. Van Der Groen, and J. L. Ceuppens. 1991. Subset markers of CD8(+) cells and their relation to enhanced cytotoxic T-cell activity during human immunodeficiency virus infection. J. Clin. Immunol. 11:345-356.
340. Van Noesel, C. J., R. A. Gruters, F. G. Terpstra, P. T. A. Schellekens, R. A. W. van Lier, and F. Miedema. 1990. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J. Clin. Invest. 86:293-299.
341. Vazeux, R., C. Lacroix-Ciaudo, S. Blanche, M.-C. Cumont, D. Henin, F. Gray, L. Boccon-Gibod, and M. Tardieu. 1992. Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am. J. Pathol. 140: 137-144.
342. Verdier, M., J. Bonis, G. Leonard, M. Dumas, and F. Denis. 1993. HTLV-1 antibody class and subclass distribution in African TSP and control populations. J. Neuroimmunol. 42:117-120.
343. Vigano, A., N. Principi, M. L. Villa, C. Riva, L. Crupi, D. Trabattoni, G. M. Shearer, and M. Clerici. 1995. Immunologic characterization of children vertically infected with human immunodeficiency virus, with slow or rapid disease. J. Pediatr. 126:368-374.
344. Viscidi, R. P., K. Mayur, H. M. Lederman, and A. D. Frankel. 1989. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246:1606-1608.
345. Vyakarnam, A., J. McKeating, A. Meager, and P. C. Beverly. 1990. Tumor necrosis factor (alpha, beta) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 4:21-27.
346. Wagner, S., and M. R. Green. 1993. HTLV-I Tax protein stimulation of DNA binding of bZIP proteins by enhancing dimerization. Science 262: 395-399.
347. Walker, B. D., and F. Plata. 1990. Cytotoxic T-lymphocytes against HIV. AIDS 4:177-184.
348. Walker, C. M., D. J. Moody, D. P. Stiles, and J. A. Levy. 1986. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234:1563-1566.
349. Weaver, C. T., C. M. Hawrylowicz, and E. R. Unanue. 1988. T helper cell subsets require the expression of distinct costimulatory signals by antigen-presenting cells. Proc. Natl. Acad. Sci. USA 85:8181-8185.
350. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
351. Weinhold, K. J., H. K. Leyerly, S. D. Stanley, A. A. Austin, T. J. Matthews, and D. P. Bolognesi. 1989. HIV-1 gp120-mediated immune suppression and lymphocyte suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142:3091-3097.
352. + channels. AIDS 5:1301-1308.
353. Westendorp, M. O., R. Frank, C. Ochsenbauer, K. Stricker, J. Dhein, H. Walczak, K.-M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (London) 375:497-500.
354. Wucherpfennig, K., P. Hollsberg, J. H. Richardson, D. Benjamin, and D. A. Hafler. 1992. T cell activation by autologous human T cell leukemia virus type I-infected T cell clones. Proc. Natl. Acad. Sci. USA 89:2110-2114.
355. Wyllie, A. H. 1980. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature (London) 284:555-556.
356. Yamada, T., S. Yamaoka, T. Goto, M. Nakai, Y. Tsujimoto, and M. Hatanaka. 1994. The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein. J. Virol. 68:3374-3379.
357. Yodoi, J., and T. Uchiyama. 1992. Diseases associated with HTLV-1: virus, IL-2 receptor dysregulation and redox regulation. Immunol. Today 13:405-411.
358. Yodoi, J., Y. Uchiyama, and M. Maeda. 1983. T-cell growth factor receptor in adult T-cell leukemia. Blood 62:509-511.
359. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747-1755.
360. Yoshida, J. 1994. Host-HTLV type I interaction at the molecular level. AIDS Res. Hum. Retroviruses 10:1193-1197.
361. Yoshida, M., J. Inoue, J. Fujisawa, and M. Seiki. 1989. Molecular mechanisms of regulation of HTLV-1 gene expression and its association with leukemogenesis. Genome 31:662-667.
362. Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human and adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. USA 79:2031-2035.
363. Yoshida, M., and M. Seiki. 1987. Recent advances in the molecular biology of HTLV-1: transactivation of viral and cellular genes. Annu. Rev. Immunol. 5:541-559.
364. + proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells. J. Immunol. 142:2279-2289.
365. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Y. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222.
366. + lymphocyte phenotype and cytokine production in long-term non-progressor and in progressor patients with HIV-1 infection. Clin. Exp. Immunol. 105:220-224.
367. Zauli, G., D. Gibellini, A. Caputo, A. Bassini, M. Negrini, M. Monne, M. Mazzoni, and S. Capitani. 1995. The human immunodeficiency virus type-1 Tat protein upregulates bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood 86:3823-3834.
368. Zauli, G., D. Gibellini, D. Milani, P. Borgatti, M. La Placa, and S. Capitani. 1993. Human immunodeficiency virus type 1 tat protein protects lymphoid, epithelial and neuronal cell lines from death by apoptosis. Cancer Res. 53:4481-4485.
369. Zhao, L. J., and C. Z. Giam. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. USA 89:7070-7074.
370. + lymphocyte subsets in acquired immune deficiency syndrome (AIDS). J. Clin. Immunol. 8:1-6.
371. 2-microglobulin and other immune characteristics in a progressive study of men at risk for acquired immunodeficiency syndrome. JAMA 22:2951-2955.